A double-blind study on the efficacy of oral dapsone in cutaneous leishmaniasis
Author:
- 1 January 1991
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 85 (2) , 212-213
Abstract
One hundred and twenty patients with localized cutaneous leishmaniasis were randomly allocated to receive tablets of dapsone (100 mg) or matching placebo tablets every 12 h for 6 weeks. No topical medication was used. Demonstration of Leishmania from skin lesions by the slit smear technique was mandatory for inclusion. Before, periodically during, and one month after completion of therapy an overall clinical assessment, haemoglobin determination, leucocyte count, and liver function tests were performed. 49 patients (82%) of those receiving dapsone were assessed as cured by clinical and parasitological criteria. Oral dapsone has certain advantages over other current forms of treatment: it is economical and widely available in countries where cutaneous leishmaniasis is common, and it is effective by mouth and well tolerated.Keywords
This publication has 5 references indexed in Scilit:
- Dapsone in the Treatment of Cutaneous LeishmaniasisInternational Journal of Dermatology, 1986
- Activity of Oral Drugs against Leishmania Tropica in Human Macrophages in VitroThe American Journal of Tropical Medicine and Hygiene, 1983
- LeishmaniasisNew England Journal of Medicine, 1979
- Metabolic studies on diphenylsulfone derivatives in chick macrophagesBiochemical Pharmacology, 1975
- The determination of sample size in treatment-control comparisons for chronic disease studies in which drop-out or non-adherence is a problemJournal of Chronic Diseases, 1967